Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Julphar
Daiichi Sankyo
McKesson
Dow
Moodys
Accenture
AstraZeneca
Citi
Chubb

Generated: April 21, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 016267

« Back to Dashboard

NDA 016267 describes DESFERAL, which is a drug marketed by Novartis and is included in one NDA. It is available from one supplier. Additional details are available on the DESFERAL profile page.

The generic ingredient in DESFERAL is deferoxamine mesylate. There are seven drug master file entries for this compound. Six suppliers are listed for this compound. Additional details are available on the deferoxamine mesylate profile page.
Summary for 016267
Tradename:DESFERAL
Applicant:Novartis
Ingredient:deferoxamine mesylate
Patents:0
Formulation / Manufacturing:see details
Pharmacology for NDA: 016267
Mechanism of ActionIron Chelating Activity
Medical Subject Heading (MeSH) Categories for 016267
Suppliers and Packaging for NDA: 016267
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
DESFERAL deferoxamine mesylate INJECTABLE;INJECTION 016267 NDA Novartis Pharmaceuticals Corporation 0078-0467 N 0078-0467-91

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:INJECTABLE;INJECTIONStrength500MG/VIAL
Approval Date:Approved Prior to Jan 1, 1982TE:APRLD:Yes

Profile for product number 002

Active Rx/OTC/Discontinued:RXDosage:INJECTABLE;INJECTIONStrength2GM/VIAL
Approval Date:May 25, 2000TE:APRLD:Yes

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

US Army
Deloitte
Fuji
Queensland Health
US Department of Justice
Harvard Business School
Chinese Patent Office
Fish and Richardson
Federal Trade Commission

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.